Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Heterogeneity in multiple sclerosis: scratching the surface of a complex disease.

Disanto G, Berlanga AJ, Handel AE, Para AE, Burrell AM, Fries A, Handunnetthi L, De Luca GC, Morahan JM.

Autoimmune Dis. 2010 Dec 9;2011:932351. doi: 10.4061/2011/932351.

2.

HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients.

Kaimen-Maciel DR, Reiche EM, Borelli SD, Morimoto HK, Melo FC, Lopes J, Dorigon RF, Cavalet C, Yamaguchi EM, Silveira TL, Da Silva WV, Comini-Frota ER, Brum Souza DG, Donadi EA.

Mol Med Rep. 2009 Nov-Dec;2(6):993-8. doi: 10.3892/mmr_00000204.

PMID:
21475933
3.

Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.

Ouadghiri S, El Alaoui Toussi K, Brick C, Ait Benhaddou EH, Benseffaj N, Benomar A, El Yahyaoui M, Essakalli M.

Pathol Biol (Paris). 2013 Dec;61(6):259-63. doi: 10.1016/j.patbio.2013.05.002. Epub 2013 Jul 9.

PMID:
23849771
4.

Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.

Binder MD, Fox AD, Merlo D, Johnson LJ, Giuffrida L, Calvert SE, Akkermann R, Ma GZ; ANZgene., Perera AA, Gresle MM, Laverick L, Foo G, Fabis-Pedrini MJ, Spelman T, Jordan MA, Baxter AG, Foote S, Butzkueven H, Kilpatrick TJ, Field J.

PLoS Genet. 2016 Mar 18;12(3):e1005853. doi: 10.1371/journal.pgen.1005853. eCollection 2016 Mar.

5.

HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.

Kwon OJ, Karni A, Israel S, Brautbar C, Amar A, Meiner Z, Abramsky O, Karussis D.

Arch Neurol. 1999 May;56(5):555-60.

PMID:
10328250
6.

The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.

Kollaee A, Ghaffarpor M, Ghlichnia HA, Ghaffari SH, Zamani M.

Int J Immunogenet. 2012 Oct;39(5):414-22. doi: 10.1111/j.1744-313X.2012.01104.x. Epub 2012 Mar 9.

PMID:
22404765
7.

Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.

Balnytė R, Rastenytė D, Vaitkus A, Skrodenienė E, Vitkauskienė A, Ulozienė I.

Medicina (Kaunas). 2016;52(4):217-222. doi: 10.1016/j.medici.2016.07.004. Epub 2016 Jul 28.

8.

Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.

Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.

Mult Scler. 2010 May;16(5):526-32. doi: 10.1177/1352458510362997. Epub 2010 Mar 5.

PMID:
20207784
9.

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.

DeLuca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, Montpetit A, Pugliatti M, Barnardo MC, Risch NJ, Sadovnick AD, Chao M, Sotgiu S, Hudson TJ, Ebers GC.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20896-901. Epub 2007 Dec 17.

10.

The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.

Ghlichnia HA, Kollaee A, Gaffarpoor M, Movafagh A, Ghlichnia B, Zamani M.

Acta Med Iran. 2014;52(6):418-23.

11.

Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis.

Link J, Kockum I, Lorentzen AR, Lie BA, Celius EG, Westerlind H, Schaffer M, Alfredsson L, Olsson T, Brynedal B, Harbo HF, Hillert J.

PLoS One. 2012;7(5):e36779. doi: 10.1371/journal.pone.0036779. Epub 2012 May 7.

12.

Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations.

Alcina A, Abad-Grau Mdel M, Fedetz M, Izquierdo G, Lucas M, Fernández O, Ndagire D, Catalá-Rabasa A, Ruiz A, Gayán J, Delgado C, Arnal C, Matesanz F.

PLoS One. 2012;7(1):e29819. doi: 10.1371/journal.pone.0029819. Epub 2012 Jan 13.

13.

Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.

Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, Gatto N, Goodkin DE, Hauser SL.

Hum Mol Genet. 1998 Aug;7(8):1229-34.

PMID:
9668163
14.

Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.

Abolfazli R, Samadzadeh S, Sabokbar T, Siroos B, Armaki SA, Aslanbeiki B, Ghelman M, Taheri T, Shakoori A.

J Neurol Sci. 2014 Oct 15;345(1-2):92-6. doi: 10.1016/j.jns.2014.07.013. Epub 2014 Jul 16.

PMID:
25064442
15.

Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.

Brill L, Mandel M, Karussis D, Petrou P, Miller K, Ben-Hur T, Karni A, Paltiel O, Israel S, Vaknin-Dembinsky A.

J Neuroimmunol. 2016 Apr 15;293:65-70. doi: 10.1016/j.jneuroim.2016.02.006. Epub 2016 Feb 15.

PMID:
27049564
16.

Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis.

Ghabaee M, Bayati A, Amri Saroukolaei S, Sahraian MA, Sanaati MH, Karimi P, Houshmand M, Sadeghian H, Hashemi Chelavi L.

Cell Mol Neurobiol. 2009 Feb;29(1):109-14. doi: 10.1007/s10571-008-9302-1. Epub 2008 Aug 26.

PMID:
18726686
17.

DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.

Fernández O, Fernández V, Alonso A, Caballero A, Luque G, Bravo M, León A, Mayorga C, Leyva L, de Ramón E.

J Neurol. 2004 Apr;251(4):440-4.

PMID:
15083289
18.

A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

Cree BA, Rioux JD, McCauley JL, Gourraud PA, Goyette P, McElroy J, De Jager P, Santaniello A, Vyse TJ, Gregersen PK, Mirel D, Hafler DA, Haines JL, Pericak-Vance MA, Compston A, Sawcer SJ, Oksenberg JR, Hauser SL; IMAGEN.; IMSGC..

PLoS One. 2010 Jun 25;5(6):e11296. doi: 10.1371/journal.pone.0011296.

19.

Multiple sclerosis: immune mechanism and update on current therapies.

Bansil S, Cook SD, Rohowsky-Kochan C.

Ann Neurol. 1995 May;37 Suppl 1:S87-101. Review.

PMID:
8968220
20.

Genetics of multiple sclerosis: linkage and association studies.

Giordano M, D'Alfonso S, Momigliano-Richiardi P.

Am J Pharmacogenomics. 2002;2(1):37-58. Review.

PMID:
12083953

Supplemental Content

Support Center